Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Effimune – product pipeline review – 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Effimune – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/Effimune-Product-Pipeline-Review-
2012-217954.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Market Direct’s pharmaceuticals report, “Effimune - Product Pipeline Review
- 2012” provides data on the Effimune’s research and development focus. The report
includes information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Effimune’s corporate website, SEC filings, investor
presentations and featured press releases, both from Effimune and industry-specific
third party sources, put together by Global Markets Direct’s team.
Scope
- Effimune - Brief Effimune overview including business description, key
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Effimune human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
2. Table of contents:
List of Tables 3
List of Figures 3
Effimune Snapshot 4
Effimune Overview 4
Key Information 4
Key Facts 4
Effimune – Research and Development Overview 5
Key Therapeutic Areas 5
Effimune – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Effimune – Pipeline Products Glance 9
Effimune – Early Stage Pipeline Products 9
Pre-Clinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Effimune – Drug Profiles 11
FR104 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
MD707 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
MF280 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MP196 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Effimune – Pipeline Analysis 15
Effimune – Pipeline Products by Therapeutic Class 15
Effimune – Pipeline Products By Target 16
3. Effimune – Pipeline Products By Mechanism of Action 17
Effimune – Recent Pipeline Updates 18
Effimune – Locations And Subsidiaries 19
Head Office 19
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1
Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012
BIOALVO S.A. – Product Pipeline Review – 2012
Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Cardio3 BioSciences SA – Product Pipeline Review – 2012
Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012
iCo Therapeutics Inc. – Product Pipeline Review – 2012
Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
4. Mersana Therapeutics, Inc. – Product Pipeline Review – 2012
Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012
Nuon Therapeutics, Inc. – Product Pipeline Review – 2012
Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012
SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012
ProStrakan Group plc – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya